Europe Incontinence Devices And Ostomy Market Industry Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The European incontinence devices and ostomy market covers a broad range of medical products designed to manage urinary and fecal continence as well as care for patients living with ostomies following surgical procedures. The region's market was valued at $17.89 billion in 2025 and is on a growth trajectory driven by aging demographics, rising prevalence of chronic conditions such as diabetes and obesity, and increasing awareness of available treatment options. The ostomy devices subsegment alone is valued at $2.11 billion in 2025 and is expected to grow at a notably faster 7.70% CAGR, outpacing the broader market.

• •Europe's incontinence and ostomy care market was valued at approximately $17.89 billion in 2025
• •The ostomy devices segment reached $2.11 billion in 2025 with a projected 7.70% CAGR through 2033
• •The overall European incontinence and ostomy care products market is forecast to reach roughly $21.64 billion by 2030

An aging European population is the primary driver, as urinary incontinence and colorectal diseases that necessitate ostomy surgery become more prevalent with age. Advances in minimally invasive surgical techniques, coupled with growing healthcare expenditure and reimbursement support across Western and Northern European nations, are expanding access to ostomy and incontinence management products. Rising patient and caregiver awareness, alongside product innovation in discreet and skin-friendly materials, is further stimulating demand.

• •High rates of surgical procedures across Europe underpin strong ostomy care market share
• •Demographic aging across the region is increasing the patient pool requiring incontinence and ostomy management
• •Healthcare infrastructure investment and reimbursement policies in major markets support broader product adoption

The market is broadly segmented into incontinence care products and ostomy care devices, with the latter including ostomy bags, skin barriers, deodorants, and accessories. The urinary incontinence segment alone is valued at approximately $3.84 billion in Europe, while the ostomy care and accessories segment stands at roughly $1.92 billion in 2025. Western Europe, including Germany, France, and the United Kingdom, leads in market revenue due to higher per capita healthcare spending, though Eastern European countries are expected to see faster relative growth as access to care improves.

• •Western Europe commands the largest share of market revenue due to high per capita healthcare expenditure
• •Urinary incontinence products represent approximately $3.84 billion of the European market
• •Eastern European markets are expected to grow at an accelerated pace as healthcare infrastructure and access expand

What are the recent trends and outlook?

Product innovation focused on patient comfort, skin health, and discreet daily wear is a defining trend, with manufacturers investing in hydrocolloid materials, odor-control technologies, and digital connectivity for product tracking. The shift toward home-based care and outpatient management is expected to drive demand for user-friendly, self-application products across both incontinence and ostomy segments. Looking ahead, the market is forecast to sustain a solid mid-single-digit growth rate, with the ostomy devices subsegment outpacing the overall market as surgical volumes increase and technology advances.

• •Innovation in skin-friendly barrier materials and odor-control features is shaping product development priorities
• •Growth in home-based and outpatient care models is increasing demand for patient-friendly, self-managing products
• •The ostomy devices segment, growing at 7.70% CAGR, is expected to outpace the broader market through 2033